The failure of the painkiller Vioxx and a lack of new products leaves the world's third-largest drug company in the lurch. Emma Marris reports.
This is a preview of subscription content, log in via an institution to check access.
Related links
Related links
Related links in Nature Research
Journal grows suspicious of Vioxx data
Painkiller verdict shows mistrust of Merck
Related external links
Rights and permissions
About this article
Cite this article
Merck opts for shake-up to clear drug pipeline. Nature 438, 1076–1077 (2005). https://doi.org/10.1038/4381076a
Published:
Issue Date:
DOI: https://doi.org/10.1038/4381076a
- Springer Nature Limited
This article is cited by
-
What goes around comes around in drug discovery
Nature (2006)